Quinlan Paul T
SEC insider (Form 3/4/5 filer). CIK 0001333277. General Counsel at Oruka Therapeutics, Inc. (ORKA). 24 reported Form 4/5 transactions since Sep 2024; latest on Oct 20, 2026. Located in MENLO PARK, CA.
Companies Quinlan Paul T has filed insider reports for
- Oruka Therapeutics, Inc. (ORKA): Officer, General Counsel
Quinlan Paul T
CIK: 0001333277
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Oruka Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Oct 20, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect1K shares at avg. $77.20$77K - Oct 20, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect500 shares at avg. $76.12$38K - Oct 20, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect3K shares at avg. $79.49$238K - Oct 20, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect4.1K shares at avg. $78.79$323K - Oct 20, 2026ORKA
Oruka Therapeutics, Inc.
ExerciseDirect9K shares at avg. $7.80$70K - Oct 20, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect400 shares at avg. $74.90$30K - Sep 21, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect601 shares at avg. $94.44$57K - Sep 21, 2026ORKA
Oruka Therapeutics, Inc.
ExerciseDirect10K shares at avg. $7.80$78K - Sep 21, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect3.8K shares at avg. $93.32$358K - Sep 21, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect2.9K shares at avg. $92.37$268K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 20, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 1,000 | $77.20 | $77,205 | Direct |
| Oct 20, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 500 | $76.12 | $38,059 | Direct |
| Oct 20, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 3,000 | $79.49 | $238,474 | Direct |
| Oct 20, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 4,100 | $78.79 | $323,037 | Direct |
| Oct 20, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise | 9,000 | $7.80 | $70,200 | Direct |
| Oct 20, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 400 | $74.90 | $29,960 | Direct |
| Sep 21, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 601 | $94.44 | $56,760 | Direct |
| Sep 21, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise | 10,000 | $7.80 | $78,000 | Direct |
| Sep 21, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 3,832 | $93.32 | $357,592 | Direct |
| Sep 21, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 2,900 | $92.37 | $267,870 | Direct |
1-10 of 24 transactions